Simultaneous quantification of trans-resveratrol and its sulfate and glucuronide metabolites in rat tissues by stable isotope-dilution UPLC-MS/MS analysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 94, Issue , 2014, Pages 99-105

  Lou, Bih Show ^a   Wu, Pei Shan ^a   Hou, Chun Wei ^b   Cheng, Fu yin ^b   Chen, Jan Kan ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

3 O d glucuronidated conjugate; 3 O sulfated conjugate; Isotope dilution; Resveratrol; UPLC MS MS

Indexed keywords

DEUTERIUM; DRUG METABOLITE; GLUCURONIDE; RESVERATOL 3 O DEXTRO GLUCURONIDE; RESVERATROL; RESVERATROL 3 O SULFATE; STABLE ISOTOPE; SULFATE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG URINE LEVEL; ELECTROSPRAY; HEART; KIDNEY PARENCHYMA; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STANDARD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

3-O-D-GLUCURONIDATED CONJUGATE; 3-O-SULFATED CONJUGATE; ISOTOPE-DILUTION; RESVERATROL; UPLC-MS/MS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONIDES; ISOTOPES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SULFATES; TANDEM MASS SPECTROMETRY;

EID: 84894232455     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.01.039     Document Type: Article

References (30)

1. Burkon A., Somoza V. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma. Mol. Nutr. Food Res. 2008, 52:549-557.
2. Harikumar K.B., Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
3. Markus M.A., Morris B.J. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin. Interv. Aging 2008, 3:331-339.
4. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. 2008, 658:68-94.
5. Hung L.M., Su M.J., Chu W.K., Chiao C.W., Chan W.F., Chen J.K. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br. J. Pharmacol. 2002, 135:1627-1633.
6. Chen K.H., Hung C.C., Hsu H.H., Jing Y.H., Yang C.W., Chen J.K. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-beta/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 2011, 190:45-53.
7. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54:111-118.
8. Udenigwe C.C., Ramprasath V.R., Aluko R.E., Jones P.J. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr. Rev. 2008, 66:445-454.
9. Das S., Das D.K. Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 2007, 6:168-173.
10. Fulda S. Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov. Today 2010, 15:757-765.
11. Juan M.E., Maijo M., Planas J.M. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed. Anal. 2010, 51:391-398.
12. Cottart C.H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 2010, 54:7-16.
13. Walle T. Bioavailability of resveratrol. Ann. N Y Acad. Sci. 2011, 1215:9-15.
14. Calamini B., Ratia K., Malkowski M.G., Cuendet M., Pezzuto J.M., Santarsiero B.D., Mesecar A.D. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 2010, 429:273-282.
15. Hoshino J., Park E.J., Kondratyuk T.P., Marler L., Pezzuto J.M., van Breemen R.B., Mo S., Li Y., Cushman M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J. Med. Chem. 2010, 53:5033-5043.
16. Storniolo C.E., Moreno J.J. Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells. Food Chem. 2012, 134:1385-1391.
17. Patel K.R., Brown V.A., Jones D.J., Britton R.G., Hemingway D., Miller A.S., West K.P., Booth T.D., Perloff M., Crowell J.A., Brenner D.E., Steward W.P., Gescher A.J., Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010, 70:7392-7399.
18. Boocock D.J., Patel K.R., Faust G.E., Normolle D.P., Marczylo T.H., Crowell J.A., Brenner D.E., Booth T.D., Gescher A., Steward W.P. Quantitation of transresveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J. Chromatogr. B 2007, 848:182-187.
19. Liu X., Teng Z., Zhang Y., Huan M., Zhou S. High performance liquid chromatography-tandem mass spectrometric determination of resveratrol and its metabolites in rat tissues. Anal. Lett. 2010, 43:557-569.
20. Muzzio M., Huang Z., Hu S.C., Johnson W.D., McCormick D.L., Kapetanovic I.M. Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs. J. Pharm. Biomed. Anal. 2012, 59:201-208.
21. Wei R., Li G., Seymour A.B. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Anal. Chem. 2010, 82:5527-5533.
22. Sabatine M.S., Liu E., Morrow D.A., Heller E., McCarroll R., Wiegand R., Berriz G.F., Roth F.P., Gerszten R.E. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005, 112:3868-3875.
23. Lindberg R., Jarnheimer P.A., Olsen B., Johansson M., Tysklind M. Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 2004, 57:1479-1488.
24. Lu Z., Cheng B., Hu Y., Zhang Y., Zou G. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chem. 2009, 113:17-20.
25. Jing Y.H., Chen K.H., Yang S.H., Kuo P.C., Chen J.K. Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling. Diabetes Metab. Res. Rev. 2010, 26:212-222.
26. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
27. Kitamura R., Matsuoka K., Matsushima E., Kawaguchi Y. Improvement in precision of the liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of 3'-C-ethynylcytidine in rat plasma. J. Chromatogr. B Biomed. Sci. Appl. 2001, 754:113-119.
28. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 2000, 11:942-950.
29. Buhrman D.L., Price P.I., Rudewicz P.J. Quantification of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: a study of ion suppression. J. Am. Soc. Mass Spectrom. 1996, 7:1099-1105.
30. Bansal S., DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 2007, 9:E109-E114.